Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease.

NCT04181359 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT04181359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04181359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease.
Lead sponsor
University of Alberta
Phase
Phase 1/2
Overall status
Withdrawn
Start date
September 1, 2024
Completion date
June 1, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dyspnea